NHS England
Printable version

Opioid prescriptions cut by almost half a million in four years as NHS continues crackdown

GPs and pharmacists have helped cut opioid prescriptions in England by 450,000 in under four years, latest data shows, as the NHS today unveils a new action plan to crack down on the overuse of potentially-addictive medicines.

The new framework for local health and care providers aims to further reduce inappropriate prescribing of high-strength painkillers and other addiction-causing medicines, like opioids and benzodiazepines, where they may no longer be the most clinically appropriate treatment for patients – and in some cases can become harmful without intervention.

The plan will support GPs and clinical pharmacists to provide patients with a personalised review of their medicines and make a shared decision about whether a change in treatment is needed, such as moving patients away from potentially-addictive prescribed drugs, especially in cases where the clinical benefit for an individual remaining on a treatment decreases.

Thanks to investment of almost £50 million over the current financial year, the NHS is already making significant progress in this area and the latest data shows that in under three years the number of opioid painkillers prescribed has fallen by 8%, which is estimated to have saved nearly 350 lives and prevented more than 2,100 incidents of patient harm.

The numbers of benzodiazepines and sleeping pills (z-drugs) prescribed in England has also fallen by 170,000 (13.9%) and 95,000 (10.2%) respectively since the NHS led the implementation of key recommendations outlined in a 2019 review by Public Health England.

The review found that in 2017/18 one in four adults in England were prescribed benzodiazepines, z-drugs, gabapentinoids, opioids for chronic non-cancer pain or antidepressants.

Now the NHS is supporting integrated care boards, community health services, public health teams and primary care networks to create personalised and innovative support for patients who have used addictive drugs or suffer from a condition that would have historically seen them prescribed such a drug, to better manage their long-term physical and mental health.

Professor Sir Stephen Powis, National Medical Director for NHS England said: “We know that patients who require prescriptions for potentially addictive drugs can become dependent and struggle with withdrawal, and this new action plan helps NHS services to continue positive work in this space having already slashed opioid prescriptions by almost half a million over the last four years.

“The plan gives clear guidance to support patients who no longer need these drugs to provide them with routine medicine reviews and move them on to other, alternative therapies where appropriate, saving both lives and taxpayer money in the process.”

Professor Tony Avery OBE, National Clinical Director for Prescribing at NHS England said: “Medicines offer a fantastic range of tools for NHS staff to provide patient care and treatment that can be positively life-changing, or even life-saving.

“However, we need to be alert to the risks of some medicines, particularly when used over a long period of time, and the framework we are publishing today empowers local services to work with people to ensure they are being effectively supported when a medicine is no longer providing overall benefit”.

One example that has already demonstrated the benefits of this step-change is ‘The Living Well with Pain Programme’ in Gloucestershire, which has taken a new approach to supporting people with long-term non-cancer pain by focusing not only on managing the impact of the pain but also people’s mental health – helping to reduce reliance on pharmaceuticals.

An evaluation of the programme over the past four years has shown a significant improvement in the mental health and wellbeing of more than eight in 10 (83%) of the people who participated in the initiative.

Cathy Stannard, clinical lead for NHS Gloucestershire’s Pain Transformation Programme, said: “In Gloucestershire we are working to change the way we think about pain and how we prescribe medications. We have worked extensively with people with lived experience, to better understand the challenges of people living with pain, and to co-design the types of services that are best for them.

“Working across our health and care partnership, including the voluntary, community and social enterprise sector, we have developed new ways to access different types of support, including visual arts, music making, animation and physical movement.

“The aim of our programme is to reduce functional limitations caused by living with persistent pain, as well as to increase mental wellbeing and emotional resilience to live well alongside pain symptoms.”

Health Minister Neil O’Brien said: “Tackling the overprescribing of opioids is important, while also ensuring patients have effective alternates.

“Painkillers can help many people manage pain, but they must be treated with caution. Some opioids are highly addictive and have the potential to cause significant harm.”

Harry, a person from Gloucester with lived experience, participates and volunteers at the Music Works, part of the Gloucestershire Creative Health Consortium.

Harry said: “I was referred to the Music Works at a chronic pain meeting, and I had no idea what to expect. I started by attending ‘the Drop’ which is a weekly open access music session, ran as part of the arts on prescription service.

“When I first started to experience pain, getting out of the house became more difficult and I found myself becoming isolated. Discovering the Music Works has really helped with the mental health impact of my pain, it’s something that I enjoy, and it is something that I really look forward to.

“I have been working with the Music Works for a long time now and as I move out of the age groups for the sessions, I am very pleased to have taken on a volunteering role”.

NHS England is encouraging local systems to adopt similar initiatives that are tailored to the needs of their population, giving people flexibility in how to manage their condition.

The framework focuses on five types of medicines, including high-strength painkillers and antidepressants, and sets out steps that local healthcare providers can take to support people who may be taking a prescribed medicine that may no longer be the best treatment for them.

The number of antidepressants prescribed since 2019/20 has increased by 8.4%, though analysis shows that the trajectory of this increase was unaffected by the COVID pandemic. The numbers of gabapentinoids prescribed have also marginally increased over the same period.

Patients should not stop taking their medicines abruptly and should discuss any next steps with their prescriber and/or health professional – this includes seeking advice from their local community pharmacist. More information can be found at www.nhs.uk/medicines/

Channel website: https://www.england.nhs.uk/

Original article link: https://www.england.nhs.uk/2023/03/opioid-prescriptions-cut-by-almost-half-a-million-in-four-years-as-nhs-continues-crackdown/

Share this article

Latest News from
NHS England

NHS rolls out discreet home-testing kits against cervical cancer for millions of women

25/08/2026 13:10:00

Nearly 4 million women will be offered HPV self-testing kits if they have not attended cervical screening appointments following invitations from the NHS in England.

The NHS is starting to roll out the new self-testing kits from today to encourage more women to complete their potentially lifesaving screening to detect human papillomavirus (HPV), which can increase the risk of cervical cancer.

England’s leading women’s health doctor described the move as a “gamechanger” given that around a third of those eligible aren’t up to date with their cervical screening, and this test provides a more “discreet and convenient option” for them.

The self-testing kit contains a swab, similar to a long cotton bud, which is used to collect a sample from the vagina. The sample is then posted back to the NHS for free, where it is checked for high-risk HPV.

If high-risk HPV is found, individuals will be invited to book a follow-up cervical screening appointment at their GP surgery or sexual health clinic, where a nurse or doctor will take a small sample from the cervix to check for cell changes.

Cervical screening helps prevent cervical cancer by checking for high-risk types of HPV. It is a common virus that can cause changes to cells in the cervix. These changes can usually be treated before cancer develops.

Women who are eligible will start receiving invitations today via the NHS App, text message, email or letter, and once invited they will be able to order a free kit through the NHS App or their NHS online account.

This is the next major step the NHS is taking in its pledge to eliminate cervical cancer by 2040, by making it as easy as possible for people to get the lifesaving HPV vaccination and increasing cervical screening attendance.

Dr Sue Mann, National Clinical Director for Women’s Health at NHS England, said: “Screening saves thousands of lives each year by preventing cancers and catching them earlier, but only around two-thirds of women are attending cervical screening appointments when invited by the NHS.

“Offering millions of women an alternative test they can do from the comfort of their own homes will be a gamechanger – making it easier than ever for them to get tested for HPV. 

“There are lots of reasons that may stop women from getting their cervical screening – embarrassment, lack of time, or worries about discomfort – and these kits provide a discreet and convenient option we hope will encourage more women to take up the life-saving test. 

“So, if you’re invited to take part, please order a test – it’s a simple swab you can do at home in minutes.”

Cervical screening appointments with a clinician remain the best way to help prevent cervical cancer, but HPV self-testing is being introduced by the NHS as an additional choice for people who have not taken up previous invitations.

HPV self-testing is an invitation-only offer and is being rolled out in phases across England as part of the NHS Cervical Screening Programme, starting with those aged between 30 and 65, who have not attended cervical screening following previous invitations.

The national rollout comes on the back of the YouScreen trial run by North London cancer alliances in collaboration with NHS England and King’s College London in 2021, which found offering self-testing kits to under-screened women at their GP practice or at home could boost the numbers screened in England by about 400,000 each year.

The UK National Screening Committee used evidence from this trial in its recommendation to roll this out wider.

The latest figures show that 68.8% of eligible women were up to date with their cervical screening – below the NHS England target of 80%. This means around 4 million women in England are not up to date with their routine check-up.

Women aged 24-64 are invited for cervical screening by the NHS every five years, or more frequently if HPV is detected.

Anyone who has been invited for cervical screening can still book an appointment at any time, even if the invitation was sent months or years ago.

It is still important to attend cervical screening appointments if you have been vaccinated against HPV as the vaccine does not provide protection from all types of HPV, so there is a still a small chance of getting cervical cancer.

People who routinely attend for a cervical screening test with a clinician at their GP practice or sexual health clinic should continue to book their appointments as normal.

Health and Social Care Secretary Yvette Cooper said: “Cervical cancer is preventable – but that’s why we want to make it as easy and convenient as possible for women to keep up with their screening.

“These free self-testing kits will be offered to four million women who are currently behind on their screening to make it easier for as many women as possible to keep themselves healthy and safe.

“This is the future NHS we are building – there for all of us when we need it, and acting as early as possible to stop preventable deaths.”

Cancer Research UK’s Chief Executive, Michelle Mitchell, said: “Cervical screening is a powerful tool that saves lives – it can prevent cervical cancer or spot it at an earlier stage when treatment is more likely to be successful. 

“While it’s best for cervical screening to be done by a nurse or doctor, there are barriers that make it challenging for some people to attend. At-home HPV self-testing kits will help more people take part in a way that works for them.

“If people receive their cervical screening or self-testing kit invitation, please consider taking up the offer and encourage loved ones to do the same. Beating cervical cancer means beating it for everyone, and this move brings us closer to that goal.”

Athena Lamnisos, Chief Executive Officer at The Eve Appeal, said: “There are many reasons why those eligible for cervical screening don’t attend.

“Challenges around the type of test it is, limited awareness around HPV and its role in cancer development, as well as practical barriers such as problems around booking and attending an appointment, stop many from going.

“Cervical screening is designed to prevent cervical cancer rather than respond to symptoms, attending a clinic requires people to actively prioritise an appointment among the many competing demands of everyday life.

“Self-testing which can be done at home will be a step-change for many. We have the incredible opportunity to see the back of cervical cancer. How brilliant would that be? But to achieve this, we need to support everyone eligible to attend screening.

“At Eve we welcome the rollout of this programme and its focus on the audiences who need it most in the first stage of the screening pathway. Looking to the future, we hope that self-testing will provide the under-screened and never screened with a new option to help address some of the key barriers. 

“This is not a replacement for clinician screening, and we will continue to work with and support those attending their traditional cervical screening, to help make their appointments more comfortable and accessible. 

“The NHS has set a 2040 target for eliminating cervical cancer. We hope that rolling out self-testing will help us reach it.”

Dawn Bryant, 62, from Hertfordshire, had cancerous cells found early thanks to NHS cervical screening and feels extremely lucky that it was detected and treated before the cancer progressed any further.

She says cervical screening may have saved her life and is encouraging other women who haven’t had theirs yet or have put it off, to book an appointment or do the at-home HPV test if invited.

“My nan died of cervical cancer when I was only 11 so I know how difficult it can be and how important cervical screening is.

“A screening test when I was 32 found I had severe high-grade cell changes, and after further testing I was told it was cancer. 

“I am so lucky it was found at an early stage and could be easily treated. I had some surgery to remove the cells, but I didn’t have to have chemotherapy, radiotherapy, or anything. It was a very scary time, but who knows what would have happened if I’d delayed having the test. 

“Since then, I have been regularly monitored, and had many tests and colposcopies, and although they can be a bit uncomfortable, I would not think twice about having them done again.

“I know lots of women who have put off having screening, and sadly, some who have been diagnosed with advanced cervical cancer after putting it off for years.

“It is so important women go for these check-ups or do the home-testing kit if invited. It doesn’t take very long and if you’re worried or have questions, the staff are excellent and will talk to you and help answer any fears you’ve got.”